Skip to main content Accessibility help
×
  • Cited by 109
    • Show more authors
    • You may already have access via personal or institutional login
    • Select format
    • Publisher:
      Cambridge University Press
      Publication date:
      08 January 2010
      31 May 2001
      ISBN:
      9780511549571
      9780521800778
      9780521154468
      Dimensions:
      (247 x 174 mm)
      Weight & Pages:
      0.933kg, 372 Pages
      Dimensions:
      (244 x 170 mm)
      Weight & Pages:
      0.5kg, 376 Pages
    You may already have access via personal or institutional login
  • Selected: Digital
    Add to cart View cart Buy from Cambridge.org

    Book description

    The thesis of this innovative and challenging book, first published in 2001, is that brain drug development has been restricted by the failure of adequate brain drug targeting, and that this is an increasingly urgent problem as developments in genomics lead to new generations of therapeutic macromolecules. The author, a world leader in the study of the blood-brain barrier and its clinical implications, reviews the field of neurotherapeutics from the point of view of drug targeting. He surveys the scientific and clinical basis of drug delivery across biological membranes, including topics such as genetically engineered trojan horses for drug targeting, antisense neurotherapeutics, and gene therapy of brain disorders. At a time when there are few significant new drug treatments in prospect for common neurological diseases, this authoritative review will encourage a wide range of clinicians and neuroscientists to reexamine the development and use of drugs in treating disorders of the central nervous system.

    Reviews

    Review of the hardback:‘… a book that will become a standard on drug targeting to the brain … a must for everybody who works in the field of brain drug delivery in academia as well as in the pharmaceutical industry.’

    W. Kamphorst - www.bmjbookshop.com

    Review of the hardback:‘This book provides an extensive review of brain drug targeting of large molecules and will be a valuable reference to those interested in completing research in this field.’

    Tejal Patel Source: Doody’s Health Sciences Book Review Journal

    Review of the hardback:‘This is an excellent book to be expected from a major researcher in the field. The lucid text is illuminated by an eclectic mix of diagrams and plates that will have a broad appeal to a wide audience.’

    A. Davenport Source: British Journal of Neurosurgery

    Refine List

    Actions for selected content:

    Select all | Deselect all
    • View selected items
    • Export citations
    • Download PDF (zip)
    • Save to Kindle
    • Save to Dropbox
    • Save to Google Drive

    Save Search

    You can save your searches here and later view and run them again in "My saved searches".

    Please provide a title, maximum of 40 characters.
    ×

    Contents

    Metrics

    Altmetric attention score

    Full text views

    Total number of HTML views: 0
    Total number of PDF views: 0 *
    Loading metrics...

    Book summary page views

    Total views: 0 *
    Loading metrics...

    * Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.

    Usage data cannot currently be displayed.

    Accessibility standard: Unknown

    Why this information is here

    This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

    Accessibility Information

    Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.